ALKERMES PLC (ALKS) Fundamental Analysis & Valuation
NASDAQ:ALKS • IE00B56GVS15
Current stock price
33.31 USD
-0.6 (-1.77%)
At close:
33.31 USD
0 (0%)
After Hours:
This ALKS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ALKS Profitability Analysis
1.1 Basic Checks
- ALKS had positive earnings in the past year.
- In the past year ALKS had a positive cash flow from operations.
- In multiple years ALKS reported negative net income over the last 5 years.
- ALKS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of ALKS (9.72%) is better than 93.41% of its industry peers.
- ALKS's Return On Equity of 13.28% is amongst the best of the industry. ALKS outperforms 93.02% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 10.90%, ALKS belongs to the top of the industry, outperforming 93.80% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ALKS is significantly below the industry average of 27.75%.
- The last Return On Invested Capital (10.90%) for ALKS is well below the 3 year average (18.21%), which needs to be investigated, but indicates that ALKS had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 13.28% | ||
| ROIC | 10.9% |
ROA(3y)14.74%
ROA(5y)6.76%
ROE(3y)22.64%
ROE(5y)9.68%
ROIC(3y)18.21%
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 16.37%, ALKS belongs to the best of the industry, outperforming 92.44% of the companies in the same industry.
- With an excellent Operating Margin value of 17.21%, ALKS belongs to the best of the industry, outperforming 92.83% of the companies in the same industry.
- ALKS has a better Gross Margin (86.69%) than 88.37% of its industry peers.
- In the last couple of years the Gross Margin of ALKS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.21% | ||
| PM (TTM) | 16.37% | ||
| GM | 86.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.55%
GM growth 5Y0.92%
2. ALKS Health Analysis
2.1 Basic Checks
- ALKS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- ALKS has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for ALKS has been increased compared to 5 years ago.
- ALKS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 6.25 indicates that ALKS is not in any danger for bankruptcy at the moment.
- ALKS has a Altman-Z score of 6.25. This is in the better half of the industry: ALKS outperforms 74.81% of its industry peers.
- There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.25 |
ROIC/WACC1.42
WACC7.67%
2.3 Liquidity
- A Current Ratio of 3.55 indicates that ALKS has no problem at all paying its short term obligations.
- ALKS has a Current ratio of 3.55. This is comparable to the rest of the industry: ALKS outperforms 43.02% of its industry peers.
- ALKS has a Quick Ratio of 3.19. This indicates that ALKS is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 3.19, ALKS is in line with its industry, outperforming 40.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.55 | ||
| Quick Ratio | 3.19 |
3. ALKS Growth Analysis
3.1 Past
- The earnings per share for ALKS have decreased strongly by -40.76% in the last year.
- Measured over the past years, ALKS shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.92% on average per year.
- Looking at the last year, ALKS shows a decrease in Revenue. The Revenue has decreased by -5.25% in the last year.
- The Revenue has been growing slightly by 7.28% on average over the past years.
EPS 1Y (TTM)-40.76%
EPS 3Y71.6%
EPS 5Y31.92%
EPS Q2Q%-72.38%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y9.9%
Revenue growth 5Y7.28%
Sales Q2Q%-10.57%
3.2 Future
- ALKS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.80% yearly.
- Based on estimates for the next years, ALKS will show a quite strong growth in Revenue. The Revenue will grow by 11.16% on average per year.
EPS Next Y-138.6%
EPS Next 2Y-36.31%
EPS Next 3Y-9.85%
EPS Next 5Y31.8%
Revenue Next Year22.19%
Revenue Next 2Y12.98%
Revenue Next 3Y10.91%
Revenue Next 5Y11.16%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ALKS Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 19.37, the valuation of ALKS can be described as rather expensive.
- Based on the Price/Earnings ratio, ALKS is valued cheaply inside the industry as 93.60% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 27.42, ALKS is valued a bit cheaper.
- The Forward Price/Earnings Ratio is negative for ALKS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.37 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ALKS is valued cheaper than 93.02% of the companies in the same industry.
- ALKS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALKS is cheaper than 97.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.53 | ||
| EV/EBITDA | 17.25 |
4.3 Compensation for Growth
- ALKS has a very decent profitability rating, which may justify a higher PE ratio.
- A cheap valuation may be justified as ALKS's earnings are expected to decrease with -9.85% in the coming years.
PEG (NY)N/A
PEG (5Y)0.61
EPS Next 2Y-36.31%
EPS Next 3Y-9.85%
5. ALKS Dividend Analysis
5.1 Amount
- ALKS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ALKS Fundamentals: All Metrics, Ratios and Statistics
33.31
-0.6 (-1.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25 2026-02-25/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners109.71%
Inst Owner Change-0.12%
Ins Owners1.59%
Ins Owner Change5.83%
Market Cap5.54B
Revenue(TTM)1.48B
Net Income(TTM)241.66M
Analysts81.67
Price Target44.46 (33.47%)
Short Float %11.64%
Short Ratio7.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.45%
Min EPS beat(2)-16.95%
Max EPS beat(2)59.84%
EPS beat(4)3
Avg EPS beat(4)31.82%
Min EPS beat(4)-16.95%
Max EPS beat(4)72.36%
EPS beat(8)4
Avg EPS beat(8)15.4%
EPS beat(12)7
Avg EPS beat(12)24.7%
EPS beat(16)10
Avg EPS beat(16)139.34%
Revenue beat(2)1
Avg Revenue beat(2)3.48%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)8.51%
Revenue beat(4)2
Avg Revenue beat(4)4.47%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)12.13%
Revenue beat(8)3
Avg Revenue beat(8)2.64%
Revenue beat(12)6
Avg Revenue beat(12)3.42%
Revenue beat(16)9
Avg Revenue beat(16)2.75%
PT rev (1m)-0.51%
PT rev (3m)-0.23%
EPS NQ rev (1m)0.29%
EPS NQ rev (3m)-495.66%
EPS NY rev (1m)-7.62%
EPS NY rev (3m)-143.54%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.37 | ||
| Fwd PE | N/A | ||
| P/S | 3.75 | ||
| P/FCF | 11.53 | ||
| P/OCF | 10.63 | ||
| P/B | 3.04 | ||
| P/tB | 3.19 | ||
| EV/EBITDA | 17.25 |
EPS(TTM)1.72
EY5.16%
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)2.89
FCFY8.67%
OCF(TTM)3.13
OCFY9.4%
SpS8.88
BVpS10.94
TBVpS10.44
PEG (NY)N/A
PEG (5Y)0.61
Graham Number20.5791 (-38.22%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 13.28% | ||
| ROCE | 13.07% | ||
| ROIC | 10.9% | ||
| ROICexc | 15.63% | ||
| ROICexgc | 16.66% | ||
| OM | 17.21% | ||
| PM (TTM) | 16.37% | ||
| GM | 86.69% | ||
| FCFM | 32.55% |
ROA(3y)14.74%
ROA(5y)6.76%
ROE(3y)22.64%
ROE(5y)9.68%
ROIC(3y)18.21%
ROIC(5y)N/A
ROICexc(3y)43.15%
ROICexc(5y)N/A
ROICexgc(3y)50.12%
ROICexgc(5y)N/A
ROCE(3y)21.84%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.55%
GM growth 5Y0.92%
F-Score6
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 148.79% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 185.24% | ||
| Profit Quality | 198.76% | ||
| Current Ratio | 3.55 | ||
| Quick Ratio | 3.19 | ||
| Altman-Z | 6.25 |
F-Score6
WACC7.67%
ROIC/WACC1.42
Cap/Depr(3y)110.09%
Cap/Depr(5y)83%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.72%
Profit Quality(3y)136.19%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.76%
EPS 3Y71.6%
EPS 5Y31.92%
EPS Q2Q%-72.38%
EPS Next Y-138.6%
EPS Next 2Y-36.31%
EPS Next 3Y-9.85%
EPS Next 5Y31.8%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y9.9%
Revenue growth 5Y7.28%
Sales Q2Q%-10.57%
Revenue Next Year22.19%
Revenue Next 2Y12.98%
Revenue Next 3Y10.91%
Revenue Next 5Y11.16%
EBIT growth 1Y-39.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.49%
EBIT Next 3Y26.34%
EBIT Next 5Y26.53%
FCF growth 1Y18.41%
FCF growth 3YN/A
FCF growth 5Y63.91%
OCF growth 1Y18.59%
OCF growth 3Y191.61%
OCF growth 5Y44.45%
ALKERMES PLC / ALKS Fundamental Analysis FAQ
What is the fundamental rating for ALKS stock?
ChartMill assigns a fundamental rating of 6 / 10 to ALKS.
What is the valuation status of ALKERMES PLC (ALKS) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.
What is the profitability of ALKS stock?
ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.
What is the valuation of ALKERMES PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ALKERMES PLC (ALKS) is 19.37 and the Price/Book (PB) ratio is 3.04.
What is the expected EPS growth for ALKERMES PLC (ALKS) stock?
The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -138.6% in the next year.